293 (Verapamil hydrochloride extended release 180 mg)
Pill imprint 293 has been identified as Verapamil hydrochloride extended release 180 mg.
Verapamil is used in the treatment of migraine prevention; cluster headaches; arrhythmia; high blood pressure; bipolar disorder (and more), and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Verapamil 180 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 293
- Strength:
- 180 mg
- Color:
- Brown
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Calcium channel blocking agents
Group IV antiarrhythmics - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc., USA
- National Drug Code (NDC):
- 68462-0293
- Inactive Ingredients:
- silicon dioxide
sodium alginate
hypromelloses
magnesium stearate
microcrystalline cellulose
povidone
titanium dioxide
polyethylene glycol 400
ferric oxide yellow
ferric oxide red
ferrosoferric oxide
More about verapamil
Consumer resources
- Verapamil
- Verapamil immediate-release
- Verapamil immediate-release tablets
- Verapamil long-acting tablets
- Verapamil sustained-release capsules controlled onset
- More (4) »
- Other brands: Calan, Verelan, Calan SR, Covera-HS, More (2) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
